What they were paid
Regulus Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2023 | $46,000 | $0 | $47,441 | $0 | $93,441 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Regulus Therapeutics Inc. DEF 14A filed April 19, 2024, accession 0001193125-24-102883, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2023Regulus Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2023 · as the proxy prints themNominating/Governance
The rest of the Regulus Therapeutics board
FY2023 · as the company reported each| Director | Role | FY2023 total |
|---|---|---|
| Alice S. Huang, Ph.D | Independent Director | $93,441 |
| David Baltimore, Ph.D | Independent Director | $95,441 |
| Jake R. Nunn | Independent Director | $97,441 |
| Joseph P. Hagan | Director | $0 |
| Kathryn J. Collier | Independent Director | $107,441 |
| Pascale Witz | Independent Director | $93,441 |
| Preston S. Klassen, M.D | Director | $0 |
| Stelios Papadopoulos, Ph.D | Chair of the Board | $131,441 |
| William H. Rastetter, Ph.D | Independent Director | $99,441 |
The full Regulus Therapeutics compensation record
free company briefThis page is one director within Regulus Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat